Cargando…
Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19
Autores principales: | Whittle, John, Molinger, Jeroen, MacLeod, David, Haines, Krista, Wischmeyer, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521195/ https://www.ncbi.nlm.nih.gov/pubmed/32988390 http://dx.doi.org/10.1186/s13054-020-03286-7 |
Ejemplares similares
-
Prolonged progressive hypermetabolism during COVID-19 hospitalization undetected by common predictive energy equations
por: Niederer, Laura E., et al.
Publicado: (2021) -
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19
por: Fudim, Marat, et al.
Publicado: (2020) -
Response to “Reassessing the death risk related to probiotics in critically ill patients”
por: Manzanares, William, et al.
Publicado: (2017) -
Evaluation of Factors Associated with Hypermetabolism and Hypometabolism in Critically Ill AKI Patients
por: de Góes, Cassiana R., et al.
Publicado: (2018) -
Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
por: Ishida, Junichi, et al.
Publicado: (2015)